News Detail
New Delhi, 29 Oct 2024: The Division Bench of Delhi High Court, on October 16, 2024, reinstated the injunction preventing Zydus Lifesciences from manufacturing, selling, or marketing its breast cancer drug Sigrima, a biosimilar of Roche’s Pertuzumab (Perjeta). The decision,......
View Details
Source : Express Pharma
cancer drug
Delhi High Court
Pertuzumab
Roche
Sigrima
Zydus
Related News
- Police caught expired cosmetic goods in Meerut, DI denied action (09-11-2024)
- Sanitary napkins, baby diapers will now need BIS certification (09-11-2024)
- New Recruitment Rules for Medical Device Regulatory Positions (09-11-2024)
- Accused caught with 400 Pregabalin capsule handed over to DCO for further action (09-11-2024)
- Telangana DCA seize narcotic drugs, psychotropic substances from private hospitals (09-11-2024)
- Govt launches Rs 500 crore scheme to strengthen medical device industry (09-11-2024)
- Baddi firm asked to stop narcotic drug production amid CID probe (09-11-2024)
- Mohali police bust unit producing fake medicine (09-11-2024)
- Delhi HC restrains Aquakind labs from using 'AQUAKIND' trademark (09-11-2024)
- MBBS from abroad, started practicing medicine without passing FMGE, Registrations cancelled (08-11-2024)